首页> 外文期刊>Biopharm international >Preparing for Your First IND Submission: The Devif is in the Details
【24h】

Preparing for Your First IND Submission: The Devif is in the Details

机译:准备首次提交IND:详细信息中有Devif

获取原文
获取原文并翻译 | 示例
       

摘要

In the process of developing breakthrough bio-Pharmaceuticals with profound therapeutic promise, the many detailed requirements for a successful investigational new drug (IND) submission may seem petty, but they are not. With an IND, you are essentially moving from the cloistered world of the laboratory into a highly regulated industry where details not only matter, but are also greatly magnified by the overriding requirements of safety and efficacy. Treat those details with forethought and you will eventually succeed. Treat them as an afterthought and all of your pioneering science, state-of-the-art technol-ogy, and therapeutic ambition could come to nothing. At the very least, your progress to market could be delayed significantly. And if, like most young biopharmaceutical companies, you are on a short financial leash, such delays can be fatal for securing additional funding.
机译:在开发具有深远治疗前景的突破性生物制药的过程中,成功提交研究性新药(IND)的许多详细要求似乎很小,但事实并非如此。有了IND,您从本质上已经从实验室的世外桃源过渡到高度管制的行业,在这个行业中,细节不仅很重要,而且对安全性和有效性的最高要求也将其大大放大。认真对待这些细节,您将最终成功。将它们视为事后想法,您所有的开创性科学,最新技术和治疗野心都将一事无成。至少,您的上市进度可能会大大延迟。而且,如果像大多数年轻的生物制药公司一样,您的财务紧缺,这种延迟对于获取额外资金可能是致命的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号